chr12-42470315-G-A
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_153026.3(PRICKLE1):c.177C>T(p.Tyr59Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00274 in 1,613,942 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_153026.3 synonymous
Scores
Clinical Significance
Conservation
Publications
- epilepsy, progressive myoclonic, 1BInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Unverricht-Lundborg syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- progressive myoclonus epilepsyInheritance: AR Classification: LIMITED Submitted by: ClinGen
- epilepsyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRICKLE1 | NM_153026.3 | c.177C>T | p.Tyr59Tyr | synonymous_variant | Exon 3 of 8 | ENST00000345127.9 | NP_694571.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00193 AC: 293AN: 152118Hom.: 2 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00353 AC: 887AN: 251274 AF XY: 0.00433 show subpopulations
GnomAD4 exome AF: 0.00282 AC: 4126AN: 1461706Hom.: 33 Cov.: 30 AF XY: 0.00328 AC XY: 2387AN XY: 727170 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00193 AC: 294AN: 152236Hom.: 2 Cov.: 32 AF XY: 0.00207 AC XY: 154AN XY: 74446 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:4
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
- -
- -
not provided Benign:2
- -
PRICKLE1: BP4, BP7, BS1, BS2 -
Epilepsy, progressive myoclonic, 1B Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at